Neuralink Launches First International Clinical Trial in Abu Dhabi for Brain-Computer Interface

Neuralink Corp., the brain-chip company led by Elon Musk, announced plans to launch its first clinical trial in the Middle East. The company stated on social media that the trial would investigate “how individuals with motor and speech impairments can use thought to control devices and communicate.” Neuralink indicated that the trial would be conducted at Cleveland Clinic Abu Dhabi in collaboration with the Department of Health – Abu Dhabi. The company also revealed that it has already implanted the device in three patients and is seeking additional participants globally to further expand the scope of the trial.

Source: STAR Market Daily

For academic sharing only. If there is any infringement, please leave a message and it will be deleted immediately!

   Join Community   

Welcome to the Brain-Computer Interface Community Exchange Group,

Exploring Topics in the Field of Brain-Computer Interfaces: Real-Time Tracking of Frontiers in Brain-Computer Interface Technology

Join WeChat Group:

Add WeChat: RoseBCI [Note: Name + Industry/Profession].

Join QQ Group: 913607986

   Call for Papers   

1. Submissions welcome. For submission inquiries, please contact us via WeChat: RoseBCI

Click to Submit:Submission Guidelines for Academic News in the Brain-Computer Interface Community

2. To join the community as a part-time creator, please contact us on WeChat: RoseBCI

One-click Triple Action: “Share,” “Like,” and “Wow”

Stay Ahead of Every Breakthrough in Brain-Computer Interface Technology